Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
94 employees
Plexium, a San Diego-based med-tech firm, pioneers first-in-class therapeutics via E3 ligases modulation.
HQ
Founded
2018
Plexium, founded in San Diego, California, is a leading medical technology company focused on developing first-in-class therapeutics by modulating E3 ligases. The company's core mission is to push the boundaries of targeted protein degradation (TPD) to improve lives. Plexium offers a comprehensive TPD platform powered by proprietary high-throughput cell-based screening (uHTS) technology, enabling the rational design and discovery of monovalent protein degraders across various modalities. Their market focus includes addressing unmet medical needs through innovative pharmaceutical solutions.
Notable affiliated individuals include experienced scientists and industry leaders who drive Plexium's pioneering research and development efforts. The company has attracted significant investment from prominent venture capital firms, underscoring confidence in its groundbreaking approach. Key achievements include the successful development of their TPD platform and the advancement of multiple therapeutic candidates. Overall, Plexium's impact lies in its potential to revolutionize the treatment landscape for various diseases through targeted protein degradation.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Therapeutics
Technology
Biotech
Tags
Healthtech
Model Types
Platform
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Plexium founded?
Plexium was founded in 2018.
Where is Plexium's headquarters located?
Plexium's headquarters is located in San Diego, CA, US.
When was Plexium's last funding round?
Plexium's most recent funding round was for $102M (USD) in February 2022.
How many employees does Plexium have?
Plexium has 94 employees as of Feb 4, 2024.
How much has Plexium raised to-date?
As of July 05, 2023, Plexium has raised a total of $165M (USD) since Feb 23, 2022.
Add Comparison
Total Raised to Date
$165M
USD
Last Update Feb 23, 2022
Last Deal Details
$102M
USD
Feb 23, 2022
Series B
Current Employees
94
Last updated: Feb 4, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts